172 related articles for article (PubMed ID: 23747847)
1. Cancer stem cell in the progression and therapy of pancreatic cancer.
Xu L
Front Biosci (Landmark Ed); 2013 Jun; 18(3):795-802. PubMed ID: 23747847
[TBL] [Abstract][Full Text] [Related]
2. Markers of pancreatic cancer stem cells and their clinical and therapeutic implications.
Gzil A; Zarębska I; Bursiewicz W; Antosik P; Grzanka D; Szylberg Ł
Mol Biol Rep; 2019 Dec; 46(6):6629-6645. PubMed ID: 31486978
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition.
Shankar S; Nall D; Tang SN; Meeker D; Passarini J; Sharma J; Srivastava RK
PLoS One; 2011 Jan; 6(1):e16530. PubMed ID: 21304978
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic cancer stem cells: emerging target for designing novel therapy.
Li Y; Kong D; Ahmad A; Bao B; Sarkar FH
Cancer Lett; 2013 Sep; 338(1):94-100. PubMed ID: 22445908
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic cancer stem cells: features and detection methods.
Ishiwata T; Matsuda Y; Yoshimura H; Sasaki N; Ishiwata S; Ishikawa N; Takubo K; Arai T; Aida J
Pathol Oncol Res; 2018 Oct; 24(4):797-805. PubMed ID: 29948612
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer stem cells and EMT in drug resistance and metastasis.
Sarkar FH; Li Y; Wang Z; Kong D
Minerva Chir; 2009 Oct; 64(5):489-500. PubMed ID: 19859039
[TBL] [Abstract][Full Text] [Related]
7. MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell.
Lu Y; Lu J; Li X; Zhu H; Fan X; Zhu S; Wang Y; Guo Q; Wang L; Huang Y; Zhu M; Wang Z
BMC Cancer; 2014 Feb; 14():85. PubMed ID: 24521357
[TBL] [Abstract][Full Text] [Related]
8. Nestin and other putative cancer stem cell markers in pancreatic cancer.
Matsuda Y; Kure S; Ishiwata T
Med Mol Morphol; 2012 Jun; 45(2):59-65. PubMed ID: 22718289
[TBL] [Abstract][Full Text] [Related]
9. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway.
Zhang L; Wang D; Li Y; Liu Y; Xie X; Wu Y; Zhou Y; Ren J; Zhang J; Zhu H; Su Z
PLoS One; 2016; 11(8):e0158529. PubMed ID: 27505247
[TBL] [Abstract][Full Text] [Related]
10. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells.
Nalls D; Tang SN; Rodova M; Srivastava RK; Shankar S
PLoS One; 2011; 6(8):e24099. PubMed ID: 21909380
[TBL] [Abstract][Full Text] [Related]
11. Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer.
Zhang Y; Wei J; Wang H; Xue X; An Y; Tang D; Yuan Z; Wang F; Wu J; Zhang J; Miao Y
Oncol Rep; 2012 May; 27(5):1599-605. PubMed ID: 22322379
[TBL] [Abstract][Full Text] [Related]
12. A concise review on the current understanding of pancreatic cancer stem cells.
Vaz AP; Ponnusamy MP; Seshacharyulu P; Batra SK
J Cancer Stem Cell Res; 2014; 2():. PubMed ID: 26451384
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia induces EMT in low and highly aggressive pancreatic tumor cells but only cells with cancer stem cell characteristics acquire pronounced migratory potential.
Salnikov AV; Liu L; Platen M; Gladkich J; Salnikova O; Ryschich E; Mattern J; Moldenhauer G; Werner J; Schemmer P; Büchler MW; Herr I
PLoS One; 2012; 7(9):e46391. PubMed ID: 23050024
[TBL] [Abstract][Full Text] [Related]
14. Isolation of stem cells from human pancreatic cancer xenografts.
Rasheed Z; Wang Q; Matsui W
J Vis Exp; 2010 Sep; (43):. PubMed ID: 20972397
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic cancer stem cells: new insight into a stubborn disease.
Zhan HX; Xu JW; Wu D; Zhang TP; Hu SY
Cancer Lett; 2015 Feb; 357(2):429-37. PubMed ID: 25499079
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
Geng S; Guo Y; Wang Q; Li L; Wang J
Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem cells and epithelial-mesenchymal transition: Novel therapeutic targets for cancer.
Ishiwata T
Pathol Int; 2016 Nov; 66(11):601-608. PubMed ID: 27510923
[TBL] [Abstract][Full Text] [Related]
18. Metabolism and epigenetics of pancreatic cancer stem cells.
Perusina Lanfranca M; Thompson JK; Bednar F; Halbrook C; Lyssiotis C; Levi B; Frankel TL
Semin Cancer Biol; 2019 Aug; 57():19-26. PubMed ID: 30273655
[TBL] [Abstract][Full Text] [Related]
19. Targeting pancreatic cancer stem cells for cancer therapy.
Xia J; Chen C; Chen Z; Miele L; Sarkar FH; Wang Z
Biochim Biophys Acta; 2012 Dec; 1826(2):385-99. PubMed ID: 22728049
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of pancreatic cancer stem cell characteristics by α-Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog.
Ma Y; Yu W; Shrivastava A; Srivastava RK; Shankar S
J Cell Mol Med; 2019 Apr; 23(4):2719-2730. PubMed ID: 30712329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
